[
  {
    "date": "2023-12-30",
    "symbol": "RNAZ",
    "period": "FY",
    "documenttype": "10-K",
    "documentannualreport": "true",
    "documentperiodenddate": "2023-12-31",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-40363",
    "entityregistrantname": "TRANSCODE THERAPEUTICS, INC.",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "81-1065054",
    "entityaddressaddressline1": "6 Liberty Square, #2382",
    "entityaddresscityortown": "Boston",
    "entityaddressstateorprovince": "MA",
    "entityaddresspostalzipcode": 2109,
    "cityareacode": 857,
    "localphonenumber": "837-3099",
    "security12btitle": "Common Stock, $0.0001Â par value per share",
    "tradingsymbol": "RNAZ",
    "securityexchangename": "NASDAQ",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "icfrauditorattestationflag": "false",
    "documentfinstmterrorcorrectionflag": "false",
    "entityshellcompany": "false",
    "entitycentralindexkey": 1829635,
    "currentfiscalyearenddate": "--12-31",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "amendmentflag": "false",
    "auditorname": "WithumSmith+Brown, PC",
    "auditorfirmid": 100,
    "auditorlocation": "East Brunswick, New Jersey",
    "cashandcashequivalentsatcarryingvalue": 2767598,
    "prepaidexpenseandotherassetscurrent": 1687846,
    "assetscurrent": 4455444,
    "propertyplantandequipmentnet": 120707,
    "operatingleaserightofuseasset": 481694,
    "securitydeposit": 111856,
    "assets": 5169701,
    "accountspayableandaccruedliabilitiescurrent": 3051259,
    "contractwithcustomerliabilitycurrent": 27057,
    "operatingleaseliabilitycurrent": 412280,
    "liabilitiescurrent": 3490596,
    "operatingleaseliabilitynoncurrent": 38291,
    "liabilities": 3528887,
    "commonstockvalue": 63,
    "additionalpaidincapital": 48057095,
    "retainedearningsaccumulateddeficit": -46416344,
    "stockholdersequity": 1640814,
    "liabilitiesandstockholdersequity": 5169701,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 290000000,
    "commonstocksharesissued": 627448,
    "commonstocksharesoutstanding": 627448,
    "researchanddevelopmentexpense": 12263530,
    "generalandadministrativeexpense": 7154986,
    "operatingexpenses": 19418516,
    "operatingincomeloss": -19418516,
    "grantincomeother": 923035,
    "interestexpense": 55899,
    "investmentincomeinterest": 5285,
    "nonoperatingincomeexpense": 872421,
    "netincomeloss": -18546095,
    "weightedaveragenumberofsharesoutstandingbasic": 179006,
    "weightedaveragenumberofdilutedsharesoutstanding": 179006,
    "earningspersharebasic": -103.61,
    "earningspersharediluted": -103.61,
    "sharesissued": 627448,
    "stockissuedduringperiodvaluenewissues": 61,
    "stockissuedduringperiodsharesnewissues": 611226,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 1036889,
    "profitloss": -18546095,
    "depreciation": 123483,
    "operatingleaserightofuseassetamortizationexpense": 393263,
    "sharebasedcompensation": 1036889,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -362912,
    "increasedecreaseinaccountspayableandaccruedliabilitiesexcludingincreasedecreaseininterestpayablenet": -1296032,
    "increasedecreaseindeferredrevenue": 27057,
    "increasedecreaseingrantreceivable": -360229,
    "increasedecreaseindepositsoutstanding": 111856,
    "increasedecreaseinoperatingleaseliability": -424385,
    "netcashprovidedbyusedinoperatingactivities": -18074535,
    "paymentstoacquirepropertyplantandequipment": 35609,
    "netcashprovidedbyusedininvestingactivities": -35609,
    "proceedsfromissuanceofcommonstock": 15909324,
    "netcashprovidedbyusedinfinancingactivities": 15909324,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -2200820,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 2767598,
    "interestpaidnet": 32861,
    "rightofuseassetsobtainedinexchangeforoperatingleaseliabilities": 874957,
    "classofwarrantorrightnumberofsecuritiescalledbywarrantsorrights": 391,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 4000,
    "propertyplantandequipmentusefullife": "P3Y",
    "stockholdersequitynotestocksplitconversionratio1": 0.05,
    "prepaidexpensecurrent": 116607,
    "otherprepaidexpensecurrent": 717686,
    "prepaidinsurance": 431061,
    "prepaidfederalinsurancecontributionact": 422492,
    "propertyplantandequipmentgross": 384050,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 263343,
    "depreciationdepletionandamortization": 123483,
    "accruedprofessionalfeescurrent": 375550,
    "accruedresearchanddevelopmentbillingscurrent": 1260578,
    "accruedgeneralexpenses": 295508,
    "accruedinsurancepremiums": 400236,
    "accruedemployeebenefitscurrent": 589404,
    "accruedlicensepaymentscurrent": 129983,
    "amountpayabletocontractresearchorganizationsandcontractmanufacturingorganizations": 1020875,
    "operatingleaserentalexpensesyearone": 37285,
    "operatingleaserentalexpensesyeartwo": 38403,
    "operatingleaserentalexpensesyearthree": 39559,
    "operatingleaseweightedaverageremainingleaseterm1": "P1Y29D",
    "operatingleaseweightedaveragediscountratepercent": 0.036,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 422464,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 38291,
    "lesseeoperatingleaseliabilitypaymentsdue": 460755,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 10184,
    "operatingleaseliability": 450571,
    "operatingleasepayments": 575192,
    "maximumtotalmilestonepayments": 1550000,
    "periodwithinwhichmilestonepaymentsshouldbepaiduponachievementofmilestone": "P60D",
    "milestonepaymentduewhenenrollmentoffirstpatientinphaseiiclinicaltrialoftherapeuticproductorprocess": 100000,
    "milestonepaymentduewhenenrollmentoffirstpatientinphaseiiiclinicaltrialoftherapeuticproductorprocess": 200000,
    "milestonepaymentduewhenfirstcommercialsaleoftherapeuticproductorprocess": 1000000,
    "milestonepaymentduewhenfilingofapplicationforregulatoryapprovalofclinicaldiagnosticproductorprocess": 100000,
    "milestonepaymentduewhenfirstregulatoryapprovalofclinicaldiagnosticproductorprocess": 150000,
    "royaltiescalculatedaspercentagetoonnetsalesoflicensedproductsfortherapeuticproductsorprocesses": 0.03,
    "royaltiescalculatedaspercentagetoonnetsalesoflicensedproductsforclinicaldiagnosticproductsandprocesses": 0.06,
    "royaltiescalculatedaspercentageofanyandallsublicenseincome": 0.3,
    "noticeperiodforterminatinglicense": "P90D",
    "periodafterfirstcommercialsalethatlicenseshallcontinueifnotterminatedbycompany": "P10Y",
    "royaltypercentagebeyondtermoflicense": 0.015,
    "minimumannuallicensefeerelatedtopatentfamily2": 10000,
    "accruedlicenseobligations": 129983,
    "contractualobligationamountpaidduringyear": 250000,
    "severancecosts1": 2483700,
    "restructuringandrelatedcostnumberofpositionseliminated": 4,
    "numberofemployees": 11,
    "accumulatedrestrictedcommonstockoutstanding": 627448,
    "accumulatedrestrictedcommonstockissued": 627440,
    "warrantsandrightsoutstandingterm": "P5Y",
    "classofwarrantorrightnumberofwarrantsorrightsissued": 7500,
    "commonstocknumberofvotespershare": 1,
    "underwriterwarrantspercentageofinitialpublicofferingprice": 1.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 6250,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 3469,
    "sharebasedcompensationarrangementbysharebasedpaymentawardtermsofaward": 10,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P2Y",
    "significantshareholderthresholdpercentageownership": 0.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardpurchasepriceofcommonstockpercent": 1,
    "sharebasedcompensationarrangementpurchasepriceforsignificantshareholders": 1.1,
    "sharebasedcompensationarrangementpurchasepriceforsignificantshareholders.": "P5Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 393,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 4243,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 2911,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 419.58,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 226.88,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 459.02,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P3Y8M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageremainingcontractualterm2": "P0Y10M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0401,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 1.006,
    "shareprice": 226.8,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 226.87,
    "allocatedsharebasedcompensationexpense": 1013527,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y3M18D",
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.06,
    "effectiveincometaxratereconciliationnondeductibleexpense": 0.015,
    "effectiveincometaxratereconciliationtaxcreditsresearch": -0.022,
    "effectiveincometaxratereconciliationsharebasedcompensationexcesstaxbenefitpercent": -0.01,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.297,
    "deferredtaxassetsoperatinglosscarryforwards": 5880202,
    "deferredtaxassetscapitalizedresearchanddevelopment": 5499242,
    "deferredtaxassetscapitalizedpatentandotherassets": 3071,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 118733,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 14125,
    "deferredtaxassetspropertyplantandequipment": 11027,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 1136299,
    "deferredtaxassetsgross": 12662699,
    "deferredtaxassetsvaluationallowance": 12662699,
    "unrecognizedtaxbenefits": 353000,
    "unrecognizedtaxbenefitsincreasesresultingfrompriorperiodtaxpositions": 228000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 125000,
    "operatinglosscarryforwards": 21556006,
    "percentageoflimitationofusageofoperatinglosses": 0.8,
    "equitymethodinvestmentownershippercentage": 0.5,
    "taxcreditcarryforwardvaluationallowance": 5506039,
    "taxcreditcarryforwardamount": 864408,
    "taxcreditcarryforwardexpirationterm": "P3Y",
    "payrolltaxprepaymentsrecordedunderact": 250000
  }
]